The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Hupperts R, Ghazi-Visser L, Silva A M, Arvanitis M, Kuusisto H, Marhardt K, Vlaikidis N, for the STAR Study Group